Eli Lilly and Company

Icagen, Inc.

Sean Patrick Hollinshead

Joseph Wendell Wilson

Philip Floyd Hughes

Jose Serafin Mendoza

Charles Howard Mitch

John S Ward

Bret E Huff

Michael A Staszak

Michael Wade Tidwell

Rossella Guidetti

Paul Leslie Ornstein

Jon Kevin Reel

Matthew Joseph Fisher

Warren Jaye Porter

Bryan Hurst Norman

Thomas Charles Britton

Kumiko Takeuchi

Michael F Gross

Sandra Ann Filla

Edward C R Smith

Serge Beaudoin

Patrick Gianpietro Spinazze

Grant Andrew McNaughton-Smith

Daniel Ray Mayhugh

George Salvatore Amato

Freddie Craig Stevens

Jeffrey Michael Schkeryantz

Kevin Matthew Gardinier

Steven Lee Kuklish

Michael Philip Cohen

Patric James Hahn

Albert Khilevich

Douglas Linn Gernert

Benjamin P Vokits

Joseph Michael Gruber

Adam Jan Sanderson

Peter Charles Astles

Ryan Thomas Backer

Adam Michael Fivush

Sarah Lynne Hellman

Veronique Dehlinger

Neil Alexander Castle

Jeffrey Michael Witkin

Benjamin Paul Vokits

A TARP &#x3b3;8 dependant AMPA receptor antagonist of the formula: wherein X is CH or N;A is andRis as defined herein;its pharmaceutically acceptable salts, uses, and methods for its preparation are described.

[object Object]

A compound of the formula: and pharmaceutical compositions for the treatment or prevention of pain.

Purine compounds

A compound of the formula: and pharmaceutical compositions for the treatment of pain.

Purine compounds used as CB2 agonists

The present invention provides selective 5-HTreceptor antagonist compounds of Formula I and their use in the treatment of migraine: 

This application relates to a substituted carboxamide compound of formula I, or a pharmaceutically acceptable salt thereof, as defined herein, a pharmaceutical composition thereof, and its use in treating pain.

Substituted carboxamides

The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.

3-indazolyl-4-pyridylisothiazoles

The present invention provides novel indane-like compounds which can be useful for treating psychosis and other conditions associated with the modulation of a muscarinic receptor. The invention provides formulations and methods for using the novel compounds.

Indane derivatives for antipsychotic compositions

Pharmaceutical compounds

The present invention relates to a compound of formula (I) which is useful for inhibiting neoplasms where the resistance is conferred in part or in total by MRP1.

Methods for inhibiting MRP1

Compounds useful as potassium channel inhibitors and especially useful for the treatment of cardiac arrhythmias and cell proliferative disorders are described.

Potassium channel inhibitors

This invention relates to a novel solid phase process for the preparation of thiophene combinatorial libraries. These libraries have use for drug discovery and are used to form wellplate components of novel assay kits.

Combinatorial process for preparing substituted thiophene libraries

Growing community of inventors

Indianapolis, IN, United States of America

Sean Patrick Hollinshead